|
Gut Symptoms in the Global Spotlight for "World Digestive Health Day" on May 29
The American College of Gastroenterology has created a special online resource center that features the College's wealth of scientifically-based education material and information, the latest related research from The American Journal of Gastroenterology and expert insight to help patients understand common gastrointestinal (GI) symptoms and how these symptoms should be appropriately treated and ...
www.newswise.com
Focus Apps Offers Free Digestive Health App in Conjunction with World Digestive Health Day
Focus Apps announces free giveaway of digestive health app thru Facebook.com to draw attention to World Digestive Health DayLos Angeles, CA (PRWEB) May 25, 2012 Focus Apps announces free giveaway of digestive health app on Facebook.com to draw attention to World Digestive Health Day. World Digestive Health Day is celebrated annually throughout the globe to increase public awareness of digestive ...
news.yahoo.com
Digestive Care, Inc. Announces FDA Approval of PERTZYE™ (pancrelipase) Delayed-Release Capsules
BETHLEHEM, Pa., May 18, 2012 /PRNewswire/ -- Digestive Care, Inc. (DCI), announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for PERTZYE™, ...
finance.yahoo.com
Ironwood and Forest to Present 17 Linaclotide-Related Abstracts at Digestive Disease Week® 2012
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced they will present linaclotide-related data in one oral presentation and 16 poster presentations during Digestive Disease Week 2012 being held in San Diego, May 19 through May 22, 2012.
finance.yahoo.com
Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2012
Salix Pharmaceuticals, Ltd. today announced that numerous presentations and educational activities related to the investigation of several of the Company’s products or relevant disease states are scheduled to take place during Digestive Disease Week DDW® 2012.
finance.yahoo.com
Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting
Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the inv
finance.yahoo.com
Synergy Pharmaceuticals to Present Abstract at Digestive Disease Week 2012
NEW YORK -- Synergy Pharmaceuticals, Inc. , a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that a poster presentation will be given at the Digestive Disease ...
finance.yahoo.com
Alvine Pharmaceuticals Presents Results from a Phase 2A Trial of ALV003 in Celiac Disease Patients at the 2012 ...
Alvine Pharmaceuticals, Inc. today announced the presentation of data from a Phase 2A trial of its lead compound, ALV003, at the 2012 Digestive Diseases Week meeting held in San Diego, California.
finance.yahoo.com
Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with ...
Sucampo Pharmaceuticals, Inc. today announced the presentation of pooled data from post-hoc analyses of the two pivotal Phase 3 studies of AMITIZA® for the treatment of irritable bowel syndrome with constipation at Digestive Disease Week 2012 in San Diego.
finance.yahoo.com
Irritable bowel syndrome clearly linked to gut bacteria
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new study which used cultures from the small intestine. This is the first study to use this “gold standard” method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.
www.sciencedaily.com
|
